Press Releases

LANCASTER, Pa., May 1, 2026 /PRNewswire/ -- Fulton Financial Corporation (NASDAQ:FULT) ("Fulton") today announced the pricing of its underwritten public offering of $300 million aggregate principal amount of its Fixed-to-Floating Rate Subordinated Notes due 2036 (the "Notes"). The Notes will bear interest from and including May 5, 2026 to, but excluding, May 15, 2031, at a fixed rate of 5.950% per annum, payable semi-annually in arrears. From and including May 15, 2031 to, but excluding, May 15, 2036 (unless redeemed prior to such date), the Notes will bear interest at a floating rate per annum equal to the Three-Month Term SOFR, plus 217 basis points, payable quarterly in arrears.

Proposals to ICC would help to lower monthly customer bills in 2027 ComEd has initiated the annual reconciliation process, which matches actual costs of service with revenues. For 2025, ComEd is submitting two reconciliation filings with the Illinois Commerce Commission (ICC), which if approved would lead to a net decrease in charges on 2027 bills relative to this year's charges. The first, a revenue reconciliation filed March 20, compares revenues billed last year and the amount approved in ComEd's current Multi-year Rate Plan. That filing is expected to result in refunds for most residential customers. The second filing, a cost reconciliation submitted today, reflects a true-up of act

VANCOUVER, British Columbia, May 01, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced the appointment of Dr. Jeymi Tambiah as Chief Medical Officer (CMO) as well as the retirement of Dr. Mark Kowalski, Eupraxia's current CMO. Dr. Jeymi Tambiah (MB ChB, FRCS, MS, FAPCR, FFPM), is a Board Certified Cardiothoracic Surgeon physician scientist who practiced at Guys and St Thomas' Hospitals prior to entering the biopharmaceutical in

MINNEAPOLIS, May 01, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced positive topline results from the PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 clinical trial evaluating gedatolisib plus fulvestrant with or without palbociclib in patients with hormone receptor positive ("HR+"), human epidermal growth factor receptor 2 negative ("HER2-"), PIK3CA mutant locally advanced or metastatic breast cancer ("ABC"), following progression on or after treatment with a CDK4/6 inhibitor and an aromatase inhibitor. Detailed results will be presented in a late-breaking abstract ("LBA")

Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A replay of

PASCAGOULA, Miss., May 01, 2026 (GLOBE NEWSWIRE) -- HII's (NYSE:HII) Ingalls Shipbuilding division hosted its annual "Signing Day" today, recognizing 49 high school seniors from across the Gulf Coast who have completed the Ingalls Shipbuilder Academy (ISA) and accepted contingent employment offers with the company. Modeled after traditional athletic signings, the ceremony celebrates students as they formally commit to launching their careers in shipbuilding. "Through the Ingalls Shipbuilder Academy, we are developing the next generation of skilled shipbuilders," said Brian Blanchette, Ingalls Shipbuilding president. "Today we celebrate their first step toward meaningful, rewarding careers

SINGAPORE, May 01, 2026 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (("Trident" or the "Company, NASDAQ:TDTH), a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore, today announced that it received a letter dated April 28, 2026 from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that since its listed securities did not have a closing bid price of at least US$1.00 for a minimum of 10 consecutive business days during the 180 calendar days ended April 27, 2026, the Company has not regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed

FALLS CHURCH, Va., May 01, 2026 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE:NOC) continues to build on its spirit of innovation, honoring suppliers who are critical partners in advancing the defense industrial base for the U.S. and its allies. Northrop Grumman's Supplier Excellence Awards recognized over 30 domestic and global suppliers whose collaboration drives cutting-edge capabilities in autonomous systems, AI-driven analytics, advanced materials and secure cloud infrastructure, technologies essential for maintaining a decisive technological edge in today's contested global security environment. With four international businesses, 16 large businesses and 18 small businesses

DESIGNATED NEWS RELEASE VANCOUVER, BC, May 1, 2026 /CNW/ - Uranium Royalty Corp. (NASDAQ:UROY) (TSX:URC) ("URC" or the "Company") has closed its previously announced private placement of subscription receipts of the Company (the "Subscription Receipts") to Uranium Energy Corp. ("UEC") at a price of US$3.64 per Subscription Receipt, for aggregate gross of US$40 million. As disclosed in the Company's news release dated April 16, 2026, each Subscription Receipt will automatically convert into one common share in the capital of URC ("URC Shares") upon all escrow release conditions set out in the subscription agreement and the subscription receipt indenture being satisfied, including the conditio

OMAHA, Neb., May 01, 2026 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE:EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced that it has acquired the outstanding shares of Monavate Holdings Limited, and Baanx.com Ltd., which were subsidiaries of W3C Corp ("W3C"), from the Receivers that were appointed in the United Kingdom to take control of these entities after W3C defaulted on a loan that was secured by these shares. The purchase price of these shares is $76.273.333.30, which is the exact amount of principal and interest outstanding on the W3C loan, as of April 30, 2026. Monavate Holdings Limited, together with its subsidiary Monavate Ltd and Baanx.com L

NOVAGOLD's Annual General Meeting of Shareholders will be held virtually on May 14, 2026, at 1:00 p.m. PDTShareholders may vote on matters before the Meeting by proxy, join the virtual Meeting and vote, and submit questions either during the webcast or in advance by emailFollowing the Meeting, Chairman Dr. Thomas S. Kaplan and President and CEO Greg Lang will discuss the strategic case for gold and NOVAGOLD's role within the broader investment thesis, building on Dr. Kaplan's extensive commentary on gold as a strategic asset. They will also highlight the latest catalysts for the Donlin Gold project — a long-life, federally permitted U.S. asset with scale and extraordinary leverage to gold.

MONTREAL, May 01, 2026 (GLOBE NEWSWIRE) -- CN (TSX:CNR) (NYSE:CNI) announced that the director nominees listed in the management information circular dated March 9, 2026 (the "Information Circular"), were elected as directors of CN. The detailed results of the vote for the election of directors held at CN's Annual Meeting of Shareholders ("Meeting") on May 1, 2026 via online webcast are set out below. Election of Directors On a vote by ballot, each of the following 11 nominees proposed by management was elected as a director of CN: NomineeVotes For % ForVotes Against % AgainstShauneen Bruder438,986,975 96.07%17,962,676 3.93%Jo-ann dePass Olsovsky430,546,313 94.22%26,403,335 5.78%David Fr

LA JOLLA, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that on May 1, 2026, the Compensation Committee of Equillium's Board of Directors granted inducement awards consisting of nonstatutory stock options to purchase an aggregate of 800,000 shares of common stock to two new employees under Equillium's 2024 Inducement Plan. The Compensation Committee approved the stock option grants as an inducement material to such employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4). Each stock option has an exercise price per share equal t

SAN FRANCISCO, May 1, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) today announced that, on April 20, 2026, the Organization and Compensation Committee of Nektar's Board of Directors granted non-qualified stock options to purchase an aggregate of 28,450 shares of its common stock and 2,950 restricted stock units (RSUs) to six newly-hired employees under Nektar's 2025 Inducement Plan. Nektar's 2025 Inducement Plan was adopted by its Board of Directors on November 6, 2025 and is used exclusively for the grant of equity awards to individuals who were not previously an emp

The Annual and Special Meeting of Shareholders (the "Meeting") of RB Global, Inc. ((the ", Company", , TSX:RBA) was held on April 30, 2026. Each of the matters voted upon at the Meeting is discussed in detail in the Company's Proxy Statement dated March 19, 2026, which can be found on the Company's website at: https://s24.q4cdn.com/560830410/files/doc_financials/2026/ar/RB-Global-2026-Proxy-Statement-As-Filed-1.pdf. Per TSX reporting requirements, the Company wishes to disclose that the total number of shares represented by shareholders in person and by proxy at the Meeting was 162,807,309 common shares of the Company and 485,000,000 Series A senior preferred shares of the Company, repres

New York, NY and Singapore, May 01, 2026 (GLOBE NEWSWIRE) -- Blueport Acquisition Ltd (NASDAQ:BPAC) ("Blueport"), a publicly traded special purpose acquisition company, and SingAuto Inc ("SingAuto"), a global innovator providing green cold-chain logistics technology solutions for smart commercial electric vehicles ("CEVs"), today announced that they have entered into a definitive business combination agreement (the "Business Combination Agreement"). Upon consummation of the business combination of Blueport and SingAuto and related transactions contemplated by the Business Combination Agreement (collectively, the "Proposed Transactions"), a newly formed holding company for the purpose of t

Consumers can now order NEREUS™ directly at nereus.usWASHINGTON, May 1, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that NEREUS™ (tradipitant) is now commercially available across the United States for the prevention of vomiting induced by motion in adults, marking the first new prescription medicine approved for this condition in more than 40 years. An innovative direct-to-consumer order platform is now available through nereus.us. Motion sickness affects an estimated 65 to 78 million Americans—roughly 25 to 30 percent of adults—during

Natuzzi S.p.A. (NYSE:NTZ) reports that, on the date hereof, it filed a Form 12b‑25 with the Securities and Exchange Commission with respect to the late filing of its Annual Report on Form 20‑F for the fiscal year ended December 31, 2025. A copy of the Form 12b‑25 is available on the Securities and Exchange Commission's website at the following link: https://www.sec.gov/Archives/edgar/data/900391/000090039126000008/nt20-f_12b_25.htm. About Natuzzi S.p.A. Founded in 1959 by Pasquale Natuzzi, Natuzzi S.p.A. is one of the most renowned brands in the production and distribution of design and luxury furniture. As of December 31, 2025, Natuzzi distributes its collections worldwide through a

MFS Investment Management ("MFS") announced today that the Board of Trustees (the "Board") of MFS Government Markets Income Trust (NYSE:MGF) and MFS Intermediate Income Trust (NYSE:MIN) (each a "Fund" and collectively, the "Funds") approved the proposed i) appointment of abrdn Inc. ("Aberdeen"), the US Subsidiary of Aberdeen Investments, the global specialist asset manager, as the new investment adviser for each Fund and ii) the election of five new trustees for each Fund in complete replacement of each Fund's current Board (collectively, the "Proposals" and each a "Proposal"). The Proposals are subject to approval by each Fund's shareholders, as discussed further below, and the satisfactio

BOSTON, May 1, 2026 /PRNewswire/ - The John Hancock closed-end funds listed below declared their monthly distributions today as follows: Declaration Date:       May 1, 2026Ex Date:                     May 11, 2026Record Date:             May 11, 2026Payment Date:          May 29, 2026TickerFund NameDistribution Per Share Change From Previous DistributionMarket Price as of 4/30/2026Annualized Current Distribution Rate at MarketHPIPreferred Income Fund I$0.1235-$16.359.06 %HPFPreferred Income Fund II$0.1235-$16.089.22 %HPSPreferred Income Fund III$0.1100-$14.838.90 %PDTPremium Dividend Fund$0.0825-$13.237.48 %HTDTax-Advantaged Dividend Income Fund$0.1580-$25.947.31 %John Hancock Premium Divide